Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vir Biotechnology, Inc. - Common Stock
(NQ:
VIR
)
8.520
+8.519 (+1064900.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vir Biotechnology, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Why Shares of Keros Therapeutics Jumped This Week
↗
April 21, 2023
The company appointed a new director and an analyst reiterated his position on the stock.
Via
The Motley Fool
Vir Biotechnology to Participate in the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
↗
April 11, 2023
The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a...
Via
Benzinga
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
↗
April 05, 2023
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.
Via
InvestorPlace
What 8 Analyst Ratings Have To Say About Vir Biotechnology
↗
April 04, 2023
Via
Benzinga
Where Vir Biotechnology Stands With Analysts
↗
February 24, 2023
Via
Benzinga
Vir Biotechnology's Earnings Outlook
↗
February 22, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
↗
February 20, 2023
Via
Benzinga
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
↗
March 21, 2023
Via
Benzinga
Biotech Stocks And The SVB Collapse — Here's What We Know
↗
March 14, 2023
The collapse of SVB will have a big impact on early-stage, venture-backed companies.
Via
Investor's Business Daily
Vir Biotechnology to Participate in the Barclays Global Healthcare Conference
March 08, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023
↗
March 06, 2023
Via
Benzinga
Vir Biotechnology Gets Price Targets Cuts By Analysts After Q4 Results
↗
March 06, 2023
Vir Biotechnology, Inc. (NASDAQ: VIR) reported worse-than-expected Q4 results. Vir Biotechnology posted a Q4 loss of $0.76 per share, versus market expectations of $0.39 per share. The company’s...
Via
Benzinga
The Top 7 Growth Stocks in Biotech
↗
March 03, 2023
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.
Via
InvestorPlace
Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Coronavirus Vaccine Market To Surpass $95 Billion By 2028
February 28, 2023
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END
Via
FinancialNewsMedia
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
February 23, 2023
Via
Benzinga
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday
↗
February 23, 2023
Goldman Sachs boosted the price target for Vir Biotechnology, Inc. (NASDAQ: VIR) from $41 to $53. Goldman Sachs analyst Paul Choi maintained a Buy rating on the stock. Vir Biotechnology shares rose...
Via
Benzinga
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)
February 22, 2023
Final draft guidance based on cost effectiveness evaluation of sotrovimab
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 23, 2023
↗
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 21, 2023
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
Via
Benzinga
Manitowoc, Helix Energy Solutions, JELD-WEN Holding And Other Big Stocks Moving Higher On Tuesday
↗
February 21, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 450 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
↗
February 21, 2023
Via
Benzinga
DraftKings To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday
↗
February 21, 2023
Wells Fargo boosted the price target for Deere & Company (NYSE: DE) from $485 to $510. Wells Fargo analyst Seth Weber maintained an Overweight rating on the stock. Deere shares fell 0.5% to $431.08 in...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
February 21, 2023
Via
Benzinga
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
February 16, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotechnology Appoints Sung Lee as Chief Financial Officer
February 16, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotech To Work On Next-Gen COVID-19 Solutions Independently, Or With Other Partners, As GSK Walks Out
↗
February 14, 2023
Vir Biotechnology Inc (NASDAQ: VIR) has amended the research collaboration agreement established with GSK plc (NYSE: GSK) in 2020.
Via
Benzinga
Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
February 14, 2023
Don’t forget to check out our premarket coverage here Fate Therapeutics, Inc. (NASDAQ: FATE) fell 4.1% to $6.13 in pre-market trading. Fate Therapeutics is expected to report Q4 results on Tuesday,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
